Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: Possible role of oxidative stress, neuroinflammation, and neurotransmitters

Physiology and Behavior

Volumn 155, Issue , 2016, Pages 180-187

  Jamwal, Sumit ^a,b   Kumar, Puneet ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b I K GUJRAL PUNJAB TECHNICAL UNIVERSITY   (India)

Author keywords

3 Nitropropionic acid; Catecholamines; GABA; Glutamate; Huntington's disease; Oxidative stress; Spermidine

Indexed keywords

3 NITROPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; ADENOSINE; CYTOKINE; DOPAMINE; GLUTAMIC ACID; GLUTATHIONE; HOMOVANILLIC ACID; HYPOXANTHINE; INOSINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID PEROXIDASE; NEUROTRANSMITTER; NITRITE; NORADRENALIN; SEROTONIN; SPERMIDINE; TUMOR NECROSIS FACTOR ALPHA; 3-NITROPROPIONIC ACID; NEUROPROTECTIVE AGENT; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE PRODUCTION; DRUG MECHANISM; GRIP STRENGTH; IN VIVO STUDY; LIPID PEROXIDATION; LOCOMOTION; MALE; MOTOR COORDINATION; NERVOUS SYSTEM INFLAMMATION; NEUROCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RANDOMIZATION; ROTAROD TEST; WISTAR RAT;

ANIMALS; BODY WEIGHT; CORPUS STRIATUM; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONATES; RANDOM ALLOCATION; RATS, WISTAR; ROTAROD PERFORMANCE TEST; SPERMIDINE;

EID: 84951088776     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2015.12.015     Document Type: Article

References (34)

1. Akula K.K., Kaur M., Bishnoi M., Kulkarni S.K. Development and validation of an RP-HPLC method for the estimation of adenosine and related purines in brain tissues of rats. J. Sep. Sci. 2008, 31(18):3139-3147.
2. Belle N.A.V., Dalmolin G.D., Fonini G., Rubin M.A., Rocha J.B.T. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res. 2004, 1008(2):245-251.
3. Blum D., Hourez R., Galas M.C., Popoli P., Schiffmann S.N. Adenosine receptors in Huntington's disease. Lancet Neurol. 2003, 2:366-374.
4. Brouillet E. The 3-NP model of striatal neurodegeneration. Curr. Protoc. Neurosci. 2014, 9(48):1-9.
5. +-ATPase activity through NMDA receptor and protein kinase G activation in the hippocampus of rats. Eur. J. Pharmacol. 2012, 684(1):79-86.
6. Chen J.Y., Wang E.A., Cepeda C., Levine M.S. Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility. Front. Neurosci. 2013, 7.
7. Choi Y.H., Park H.Y. Anti-inflammatory effects of spermidine in lipopolysaccharide-stimulated BV2 microglial cells. J. Biomed. Sci. 2012, 19(1):31.
8. Classics Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
9. Coert B.A., Anderson R.E., Meyer F.B. Exogenous spermine reduces ischemic damage in a model of focal cerebral ischemia in the rat. Neurosci. Lett. 2000, 282(1):5-8.
10. Donzanti B.A., Yamamoto B.K. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci. 1988, 43(11):913-922.
11. Drew P.D., Chavis J.A. Inhibition of microglial cell activation by cortisol. Brain Res. Bull. 2000, 52(5):391-396.
12. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82(1):70-77.
13. Eisenberg T., Knauer H., Schauer A., Büttner S., Ruckenstuhl C., Carmona Gutierrez D., et al. Induction of autophagy by spermidine promotes longevity. Nat. Cell Biol. 2009, 11:1305-1314.
14. Gallagher M.J., Huang H., Grant E.R., Lynch D.R. The NR2B-specific interactions of polyamines and protons with the N-methyl-d-aspartate receptor. J. Biol. Chem. 1997, 272(40):24971-24979.
15. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 1982, 126(1):131-138.
16. + in rat hippocampus. Brain Res. 1994, 658(1):39-48.
17. Kim G.W., Copin J.-C., Kawase M., Chen S.F., Sato S., Gobbel G.T., et al. Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid. J. Cereb. Blood Flow Metab. 2000, 20(1):119-129.
18. Khan A., Jamwal S., Bijjem K., Prakash A., Kumar P. Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats. Neuroscience 2015, 287:66-77.
19. Kumar P., Kalonia H., Kumar A. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur. J. Pharmacol. 2012, 674(2):265-274.
20. Kumar P., Kalonia H., Kumar A. Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain. Drug Chem. Toxicol. 2010, 33(4):377-392.
21. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 2001, 79(3):463-484.
22. Kumar P., Kumar P., Khan A., Deshmukh R., Lal S.P. Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats. Eur. J. Pharmacol. 2014, 723:38-45.
23. Lewandowski N.M., Ju S., Verbitsky M., Ross B., Geddie M.L., Rockenstein E., et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc. Natl. Acad. Sci. 2010, 107(39):16970-16975.
24. Lovaas E., Carlin G. Spermine: an anti-oxidant and anti-inflammatory agent. Free Radic. Biol. Med. 1991, 11(5):455-461.
25. Lovaas E. Antioxidative and metal-chelating effects of PolyaminesI. Antioxid. Dis. Mech. Ther.: Antioxid. Dis. Mech. Ther. Strateg. 1996, 38:119.
26. Milnerwood A.J., Gladding C.M., Pouladi M.A., Kaufman A.M., Hines R.M., Boyd J.D., et al. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron 2010, 65(2):178-190.
27. Minois N., Carmona-Gutierrez D., Madeo F. Polyamines in aging and disease. Aging (Albany NY) 2011, 3(8):716.
28. Minois N. Molecular basis of the 'anti-aging' effect of spermidine and other natural polyamines-a mini-review. Gerontology 2014, 60(4):319-326.
29. Minois N., Rockenfeller P., Smith T.K., Carmona-Gutierrez D. Spermidine feeding decreases age-related locomotor activity loss and induces changes in lipid composition. PLoS One 2014, 9(7):e102435.
30. Ooi J., Hayden M.R., Pouladi M.A. Inhibition of excessive monoamine oxidase A/B activity protects against stress-induced neuronal death in Huntington disease. Mol. Neurobiol. 2015, 52:1850-1861.
31. Tunez I., Tasset I., Pérez-De La Cruz V., Santamaría A. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules 2010, 15(2):878-916.
32. Thangarajan S., Deivasigamani A., Natarajan S.S., Krishnan P., Mohanan S.K. Neuroprotective activity of l-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Int. J. Neurosci. 2014, 124(9):673-684.
33. Velloso N.A., Dalmolin G.D., Fonini G., Gindri Sinhorin V.D., Ferreira da Silveira A., Rubin M.A., et al. Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats. Brain Res. 2008, 1198:107-114.
34. Wills E. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. 1966, 99:667-676.